Supplement encyclopedia

Ophiocordyceps sinensis

Chinese cordyceps (Ophiocordyceps sinensis) is a fungus whose wild form grows on insect larvae. Various cultured preparations are also sold under the name “cordyceps.” It is important to distinguish these preparations by the organism used, their composition, and how they are produced.

Double-check the conclusions and review the sources before choosing a supplement.

Main conclusion

Potential benefits

  • A drink containing cordyceps fermentation broth made by Qinghai Mingyuewang may improve perceived sleep quality in adults with insomnia. Over four weeks, the sleep-problem score decreased by 6.45 points versus 1 point with placebo.
  • In competitive cyclists, CordyMax Cs-4 showed no convincing advantage in a cycling time trial or peak oxygen uptake over five weeks.
  • In a small experiment in male long-distance runners, maximum oxygen uptake during exercise was 55.8 versus 53.7 mL/kg/min with placebo after two weeks of powder labeled C. sinensis. This measures how much oxygen the body uses during maximal exertion.
  • A product labeled C. sinensis may help maintain higher average power in repeated sprints. This result was reported in female soccer players after four weeks of use alongside sprint training.
  • In adults with persistent COVID symptoms, symptom and fatigue scores were lower after 12 weeks of cultivated Cs4 mycelium extract than in the waiting-list group. Participants knew who was receiving capsules.

[1] [2] [3] [4] [5]

What researchers studied

  • In healthy people aged 50–75, the overall assessment of endurance measures found no convincing difference from placebo over 12 weeks of Cs-4 use.
  • In the drink trial, three of 44 participants reported more frequent stools; this resolved within one to three days.
  • In a sample of 65 Thai cordyceps products sold online, four screened positive for corticosteroids. When choosing, check the product’s origin and quality control.

[1] [2] [3]

Forms studied

  • For sleep, the study used 150 mL of fermented drink six days per week for four weeks. This volume refers to the ready-to-drink product.
  • The cyclist experiment used CordyMax Cs-4 at 3.15 g daily for five weeks. The female soccer player study used a different product labeled C. sinensis at 3 g daily for four weeks.
  • Cultivated Cs-4 is listed as Paecilomyces hepiali in the Canadian register; wild Ophiocordyceps sinensis and cultivated preparations differ in origin. Look for the organism’s name and production method on the label.

[1] [2] [3] [4] [5]

How to get it from food

  • Wild cordyceps is traditionally used in soups and dishes with duck or chicken.
  • It is also described as an infusion or as powder added to liquid or soup. Composition depends on the raw material and preparation.

[1]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Maximal oxygen uptake: VO₂maxVO2max was 55.8 versus 53.7 mL/kg/min in a small study. Product identity and reproducibility have not been established.
1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.
11 publication describedApplying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗12 men who were long-distance runners (crossover study)
  1. Applying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗
Peak oxygen uptake: VO₂peakThe study in cyclists found no significant benefit for this outcome.
2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.
11 publication describedCordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗22 men who were competitive cyclists
  1. Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗
Cycling time trialThe study in cyclists found no significant benefit for this outcome.
2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.
11 publication describedCordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗22 men who were competitive cyclists
  1. Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Forms

Wild fungus and cultured preparations: The Cs-4 designation does not establish the identity of every batch. The Canadian registry lists cultured Cs-4 as Paecilomyces hepiali, and a molecular study linked Hirsutella sinensis to O. sinensis. Fermentation beverage: The sleep trial used 150 mL six days per week. The amount of the fungal component was not reported. This volume of the beverage cannot be equated with a dose in grams of another preparation. The sources reviewed give no established daily intake or tolerable upper intake level for cordyceps. The doses used in studies apply to specific products.

Guidance for each goal

Maximal oxygen uptake: VO₂max1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

VO2max was 55.8 versus 53.7 mL/kg/min in a small study. Product identity and reproducibility have not been established.

Study findings. VO2max was 55.8 versus 53.7 mL/kg/min in a small study. Product identity and reproducibility have not been established.

Studied regimen3 g/dayPowder labeled C. sinensis
Duration and populationTwo weeks12 men who were long-distance runners (crossover study)

Comparator: Placebo with stevia

Peak oxygen uptake: VO₂peak2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

The study in cyclists found no significant benefit for this outcome.

Study findings. The study in cyclists found no significant benefit for this outcome.

Studied regimen3.15 g/dayCordyMax Cs-4 preparation
Duration and populationFive weeks22 men who were competitive cyclists

Comparator: Placebo

Cycling time trial2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

The study in cyclists found no significant benefit for this outcome.

Study findings. The study in cyclists found no significant benefit for this outcome.

Studied regimen3.15 g/dayCordyMax Cs-4 preparation
Duration and populationFive weeks22 men who were competitive cyclists

Comparator: Placebo

Endurance measures and overall between-group test2/4 LowRead moreCollapse
Confidence
2/4 LowThe risk of bias assessment notes limitations related to blinding, attrition, or verification of the original study plan. Heterogeneity cannot be assessed from a single study. With no additional grounds for downgrading, confidence was not further downgraded for inconsistency. The assessment applies only to the population, product, and outcome studied. Confidence was not further downgraded on applicability grounds. A small sample, an unavailable confidence interval, or both limit the precision of the estimate. Confidence was not further downgraded for possible publication bias because there were no specific grounds for doing so, although unpublished results cannot be ruled out.

The overall multivariate test found no difference between groups. Isolated within-group changes in thresholds do not establish an advantage.

Study findings. The overall multivariate test found no difference between groups. Isolated within-group changes in thresholds do not establish an advantage.

Studied regimenAbstract: 333 mg three times daily (0.999 g/day). Methods: three 333 mg capsules three times daily (2.997 g/day). The exact dose is unclear.Cs-4 preparation
Duration and population12 weeks20 healthy people aged 50–75 enrolled, and 15 completed the study

Comparator: Placebo with starch

Mean power output, main effect of supplementation1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

The authors reported a main effect of supplementation on mean power output during repeated sprints (p = 0.01). No statistically significant interaction between conditions was detected.

Study findings. The authors reported a main effect of supplementation on mean power output during repeated sprints (p=0.01). No statistically significant interaction between conditions was detected.

Studied regimen3 g/dayProduct labeled C. sinensis
Duration and populationFour weeks39 female soccer players in four training groups

Comparator: Placebo during sprint training under normal or reduced oxygen conditions

Change in mean power output1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

In the hypoxic groups, mean power output changed from 3.65 to 4.77 W/kg versus 3.85 to 4.52 W/kg. The interaction between conditions was not statistically significant.

Study findings. In the hypoxic groups, mean power output changed from 3.65 to 4.77 W/kg versus 3.85 to 4.52 W/kg. The interaction between conditions was not statistically significant.

Studied regimen3 g/dayProduct labeled C. sinensis
Duration and populationFour weeks22 female soccer players in the reduced-oxygen training groups

Comparator: Placebo during the same reduced-oxygen sprint training

Sleep quality measured with the PSQI questionnaire2/4 LowRead moreCollapse
Confidence
2/4 LowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

Over four weeks, the sleep questionnaire score fell by 6.45 points with the fermentation beverage and by 1.00 point with placebo. Lower scores indicate better self-rated sleep.

Study findings. Over four weeks, the sleep questionnaire score fell by 6.45 points with the fermentation beverage and by 1.00 point with placebo. Lower scores indicate better self-rated sleep.

Studied regimen150 mL six days per week. The amount of the fungal component was not reported.Beverage containing cordyceps fermentation broth, manufactured by Qinghai Mingyuewang
Duration and populationFour weeks90 adults with primary insomnia were randomized, and 44 in each group completed the study

Comparator: The same beverage without the fermentation broth. Both groups used an app.

Severity of long COVID symptoms1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The open-label comparison and subjective outcomes create a high risk that expectations influenced the results. Consistency across studies: Heterogeneity cannot be assessed from a single study, and there are no additional grounds for downgrading. Confidence was not further downgraded on this basis. Applicability to the specified group: The assessment applies only to the population, product, and outcome studied. Confidence was not further downgraded on this basis. Precision of the estimate: A small sample and/or an unavailable confidence interval limit precision. Possible publication bias: There are no specific grounds for an additional downgrade, although unpublished results cannot be ruled out. Confidence was not further downgraded on this basis.

At 12 weeks, the symptom score was 8.7 points lower (95% CI −12.7 to −4.8) after adjusting for time since the last infection. Participants knew whether they were receiving the capsules, which may have influenced their responses.

Study findings. At 12 weeks, the symptom score was 8.7 points lower (95% CI −12.7 to −4.8) after adjusting for time since the last infection. Participants knew whether they were receiving the capsules, which may have influenced their responses.

Studied regimenFour 0.4 g capsules per day (1.6 g/day)Capsules containing an extract of cultured Cs4 mycelium, manufactured by Chinese Pharm
Duration and population12 weeks110 adults with persistent COVID symptoms were randomized, and 100 completed the trial

Comparator: Open-label comparison with a waitlist control. The control group received no Cs4 for the first 12 weeks.

Fatigue measured by questionnaire1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowRisk of bias: The reported limitations concern blinding, missing data, outcome selection, or product identity. Consistency across studies: No inconsistency in results has been established for this product and specific comparison. Confidence was not further downgraded on this basis. Applicability to the specified group: The conclusion applies only to the specified culture, group, and outcome. Confidence was not further downgraded on this basis. Precision of the estimate: The sample is small, uncertainty is high, or the confidence interval is unavailable. Possible publication bias: There are too few studies to assess publication bias reliably, and there is no direct evidence of missing studies. Confidence was not further downgraded on this basis.

At 12 weeks, the Brief Fatigue Inventory (BFI) score was 8.1 points lower (95% CI −14.2 to −2.0). Participants knew whether they were receiving the capsules, which may have influenced their responses.

Study findings. At 12 weeks, the Brief Fatigue Inventory (BFI) score was 8.1 points lower (95% CI −14.2 to −2.0). Participants knew whether they were receiving the capsules, which may have influenced their responses.

Studied regimenFour 0.4 g capsules per day (1.6 g/day)Capsules containing an extract of cultured Cs4 mycelium, manufactured by Chinese Pharm
Duration and population12 weeks110 adults with persistent COVID symptoms were randomized, and 100 completed the trial

Comparator: Open-label comparison with a waitlist control. The control group received no Cs4 for the first 12 weeks.

Safety and limitations

In the trial of the fermentation beverage, 3 of 44 participants in the active group reported going to the bathroom more often. This resolved in 1–3 days. The researchers did not establish the cause. Of 65 products sampled from the Thai online market, 4 screened positive for corticosteroids. The screening did not identify any specific steroids or provide an estimate of worldwide frequency. Different forms of arsenic have been measured in wild cordyceps. Their toxicity and the applicability of these findings to cultured preparations are uncertain. In the 48-week Bailing trial, adverse events were recorded in 29.6% of participants in the Bailing group and 30.4% of participants in the placebo group. These data apply to the specific preparation and group studied.

Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool ↗ · Post-marketing surveillance of cordyceps products online: identifying falsified products and regulatory challenges ↗ · Determination of Arsenic Species in Ophiocordyceps sinensis from Major Habitats in China by HPLC-ICP-MS and the Edible Hazard Assessment ↗ · Efficacy and safety of Cordyceps sinensis (Hirsutella sinensis, Cs-C-Q80) in chronic bronchitis ↗

Interactions

WithEffectActionSource
Blood sugar–lowering medicines and anticoagulantsLaboratory studies suggest that cordyceps may amplify the effects of medicines that lower blood sugar or reduce blood clotting. One case of severe bleeding after a tooth extraction was reported in a person taking cordyceps.Before combining them, review the specific medication and the supplement’s ingredients with a doctor or pharmacist.Cordyceps — Memorial Sloan Kettering Cancer Center ↗

Food sources

Food composition

FoodGroupAmountServingCaloriesSources
Cordyceps in duck soupWild cordyceps used as an ingredient in a cooked dishTraditional dishes and beverages—One documented culinary use of wild cordyceps in China.——Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗
Cordyceps in a chicken dishWild cordyceps after cookingTraditional dishes and beverages—A botanical review describes cooking wild cordyceps with chicken. This material differs from what is used in Cs-4 capsules.——Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗
Wild cordyceps infusionWater-based beverageTraditional dishes and beverages—Use as a tea or infusion has been described. The composition of the beverage depends on the starting material and the method of preparation.——Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗
Powder in soup or a beverageGround raw material of natural originTraditional dishes and beverages—The powder is added to a liquid or soup. An amount of this raw material in grams should not be treated as equivalent to the same weight of a separate cultured product.——Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗

Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Applying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗Maximal oxygen uptake: VO₂max12 men who were long-distance runners (crossover study)Powder labeled C. sinensis; 3 g/day; Two weeks; comparator: Placebo with steviaVO2max was 55.8 versus 53.7 mL/kg/min in a small study. Product identity and reproducibility have not been established.
Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗Peak oxygen uptake: VO₂peak: Peak oxygen uptake: VO₂peak Cycling time trial: Cycling time trialPeak oxygen uptake: VO₂peak: 22 male competitive cyclists Cycling time trial: 22 male competitive cyclistsPeak oxygen uptake: VO₂peak: CordyMax Cs-4 preparation; 3.15 g/day; Five weeks; comparator: Placebo Cycling time trial: CordyMax Cs-4 preparation; 3.15 g/day; Five weeks; comparator: PlaceboPeak oxygen uptake: VO₂peak: The study in cyclists found no significant benefit for this outcome. Cycling time trial: The study in cyclists found no significant benefit for this outcome.

Sources

Sources
  1. Applying Cordyceps sinensis to Boost Endurance Performance in Long-Distance Runners ↗
  2. Cordyceps Sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance ↗
  3. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial ↗
  4. Effect of Cordyceps Sinensis on repeated-sprint performance following repeated-sprint training in hypoxia in female soccer players ↗
  5. Effectiveness of fermentation broth of Cordyceps sinensis for primary insomnia: a randomized clinical trial with digital health tool ↗
  6. Efficacy and safety of Cordyceps sinensis (Hirsutella sinensis, Cs-C-Q80) in chronic bronchitis ↗
  7. Cordyceps sinensis (a Chinese medicinal herb) for treating chronic kidney disease | Cochrane ↗
  8. Randomized, waitlist-controlled trial of Cordyceps sinensis mycelium culture extract (Cs4) for long COVID patients in Hong Kong ↗
  9. Cordyceps (cultured) — Natural Health Products Ingredients Database (Health Canada) ↗
  10. Isolation, Culture and Characterization of Hirsutella sinensis Mycelium from Caterpillar Fungus Fruiting Body ↗
  11. Post-marketing surveillance of cordyceps products online: identifying falsified products and regulatory challenges ↗
  12. Determination of Arsenic Species in Ophiocordyceps sinensis from Major Habitats in China by HPLC-ICP-MS and the Edible Hazard Assessment ↗
  13. Cordyceps — Memorial Sloan Kettering Cancer Center ↗
  14. Cordyceps — Botanical Adulterants Prevention Bulletin, October 2024 ↗